Nationwide Response to Carboplatin and Cisplatin Shortages in Lung Cancer

Key Points

• Patient treatment options diminished due to cisplatin and carboplatin shortages, complicating lung cancer management.
• The study highlights the impact of drug shortages on effective therapeutic strategies in lung cancer care.
• Observational analysis across healthcare settings reveals significant consequences of the shortages on patient outcomes.
• Understanding these drug supply issues may help inform future policies to mitigate similar crises.